Research Article

Betel Nut Chewing and Subclinical Ischemic Heart Disease in Diabetic Patients

Table 1

Comparisons between patients chewing and not chewing betel nut and having and not having subclinical ischemic heart disease (IHD).

Betel nut chewingSubclinical IHD
NoYesNoYes

n3494532371
Age, years63.9 (9.3)56.3 (8.6)**62.0 (9.4)67.6 (9.1)**
Diabetic duration, years10.4 (7.6)10.3 (8.8)10.4 (7.6)10.7 (8.5)
Body mass index, kg/m224.5 (3.0)25.9 (3.7)**24.6 (3.2)24.8 (2.9)
Smoking, %60.586.7**63.264.8
Fasting plasma glucose, mg/dL159.4 (57.3)178.6 (74.8)*162.2 (56.5)159.1 (72.9)
Hypertension, %52.460.052.357.8
Systolic blood pressure, mmHg132.8 (15.8)131.9 (16.1)132.1 (15.4)135.2 (17.5)
Diastolic blood pressure, mmHg83.2 (8.8)84.8 (7.0)83.4 (8.4)83.1 (9.6)
Dyslipidemia, %56.068.956.562.0
Total cholesterol, mg/dL199.8 (45.9)196.9 (38.2)199.1 (45.1)201.3 (44.9)
Triglyceride, mg/dL168.7 (193.3)180.0 (83.1)168.9 (196.2)174.9 (114.6)
Ischemic heart disease, %16.628.9*
Betel nut chewing, %9.918.0*

𝑃 < . 0 5 ; 𝑃 < . 0 1 .